sc 51089 has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobrowolski, P; Doré, S; Kapoor, N; Kim, YT; Langer, J; Li, RC; Maruyama, T; Narumiya, S; Yocum, J; Zhen, G | 1 |
| Keene, CD; Li, X; Montine, KS; Montine, TJ; Rose, SE | 1 |
1 review(s) available for sc 51089 and Encephalopathy, Toxic
| Article | Year |
|---|---|
Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitro.
Topics: Amyloid beta-Peptides; Animals; Blotting, Western; Calcium Channel Blockers; Cell Line, Tumor; Cells, Cultured; Coloring Agents; Dinoprostone; Humans; Hydrazines; Mice; Mice, Inbred C57BL; Neurons; Neurotoxicity Syndromes; Nimodipine; Oxazepines; Peptide Fragments; Prostaglandin Antagonists; Receptors, Prostaglandin E, EP1 Subtype; Tetrazolium Salts; Thiazoles | 2013 |
1 other study(ies) available for sc 51089 and Encephalopathy, Toxic
| Article | Year |
|---|---|
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Brain; Brain Ischemia; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucose; Hippocampus; Humans; Hydrazines; Hypoxia; Male; Mice; Mice, Transgenic; Neurons; Neurotoxicity Syndromes; Oxazepines; Peptide Fragments; Presenilin-1; Receptors, Prostaglandin E, EP1 Subtype | 2012 |